↓ Skip to main content

Chronic HCV infection: epidemiological and clinical relevance

Overview of attention for article published in BMC Infectious Diseases, November 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
5 news outlets
twitter
1 X user
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
93 Dimensions

Readers on

mendeley
166 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Chronic HCV infection: epidemiological and clinical relevance
Published in
BMC Infectious Diseases, November 2012
DOI 10.1186/1471-2334-12-s2-s2
Pubmed ID
Authors

S Zaltron, A Spinetti, L Biasi, C Baiguera, F Castelli

Abstract

Hepatitis C virus (HCV), first recognized as a cause of transfusion-associated acute and chronic hepatitis in 1989, plays a major role as a cause of chronic liver injury, with potential for neoplastic degeneration. It is mainly transmitted by the parenteral route. However, although with lower efficiency, it may be also transmitted by sexual intercourses and by the mother-to-child route. Epidemiological evidence shows that a wave of infection occurred in the 1945-65 period (baby boomers) in western countries. After acute infection, as many as 50-85% of the patients fail to clear the virus resulting in chronic liver infection and/or disease. It is estimated that, on a global scale, about 170 million people are chronically infected with HCV, leading to about 350.000 deaths yearly. Among western countries southern Europe, and particularly Italy, is among the most affected areas. The impact on the public health systems is noteworthy, with high number of hospitalizations due to chronic liver disease, cirrhosis or hepatocellular carcinoma. While waiting for a safe and effective vaccine to be made available, new promising direct-acting antiviral (DAA) drugs offer a better therapeutic scenario than in the past even for the poor responder genotypes 1 and 4, provided that effective screening and care is offered. However, the long and aspecific prodromic period before clinical symptoms develop is a major obstacle to early detection and treatment. Effective screening strategies may target at-risk groups or age specific groups, as recently recommended by the CDC.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 166 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 2 1%
Germany 1 <1%
Brazil 1 <1%
United Kingdom 1 <1%
Egypt 1 <1%
China 1 <1%
Unknown 159 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 30 18%
Student > Bachelor 19 11%
Researcher 17 10%
Student > Ph. D. Student 17 10%
Student > Doctoral Student 13 8%
Other 26 16%
Unknown 44 27%
Readers by discipline Count As %
Medicine and Dentistry 50 30%
Agricultural and Biological Sciences 25 15%
Immunology and Microbiology 13 8%
Nursing and Health Professions 9 5%
Biochemistry, Genetics and Molecular Biology 4 2%
Other 18 11%
Unknown 47 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 42. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 January 2024.
All research outputs
#975,166
of 25,331,507 outputs
Outputs from BMC Infectious Diseases
#225
of 8,540 outputs
Outputs of similar age
#5,242
of 185,890 outputs
Outputs of similar age from BMC Infectious Diseases
#3
of 152 outputs
Altmetric has tracked 25,331,507 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,540 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.7. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 185,890 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 152 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.